Cartesian Therapeutics, Inc. Interest Payable, Current
Cartesian Therapeutics, Inc. (RNAC) had Interest Payable, Current of $44.00 thousand as of 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2020-08-06
- 2020-06-30: Interest Payable, Current $44.00K.
- 2020-03-31: Interest Payable, Current $60.00K.
- 2019-12-31: Interest Payable, Current $82.00K.
- 2019-09-30: Interest Payable, Current $96.00K.
| Period end | Interest Payable, Current |
|---|---|
| 2020-06-30 | $44.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $60.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $82.00K 10-Q · filed 2020-08-06 |
| 2019-09-30 | $96.00K 10-Q · filed 2019-11-08 |
| 2019-06-30 | $105.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $109.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $106.00K 10-K · filed 2020-03-12 |
| 2018-09-30 | $97.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $94.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $92.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $89.00K 10-K · filed 2019-03-15 |
| 2017-09-30 | $47.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $69.00K 10-Q · filed 2017-08-11 |
| 2017-03-31 | $76.00K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $81.00K 10-K · filed 2018-03-15 |
| 2015-12-31 | $34.00K 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |